|
gptkbp:instanceOf
|
vaccine
|
|
gptkbp:age
|
adults
children
infants
|
|
gptkbp:alsoKnownAs
|
gptkb:PCV13
gptkb:Pneumococcal_13-valent_Conjugate_Vaccine
|
|
gptkbp:approvedBy
|
gptkb:FDA
gptkb:EMA
2010
|
|
gptkbp:ATCCode
|
gptkb:J07AL02
|
|
gptkbp:broadcastOn
|
multiple doses
|
|
gptkbp:contains
|
gptkb:CRM197_protein
polysaccharide antigens
|
|
gptkbp:contraindication
|
severe allergic reaction to any component
|
|
gptkbp:countryOfOperation
|
gptkb:Australia
gptkb:Canada
gptkb:European_Union
gptkb:United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Prevnar 13
|
|
gptkbp:indication
|
prevention of pneumococcal disease
|
|
gptkbp:manufacturer
|
gptkb:Pfizer
|
|
gptkbp:numberOfSerotypes
|
13
|
|
gptkbp:prescriptionStatus
|
prescription only
|
|
gptkbp:protectedBy
|
gptkb:Streptococcus_pneumoniae
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
|
|
gptkbp:sideEffect
|
fever
fatigue
injection site pain
irritability
|
|
gptkbp:storage
|
2-8°C
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:Wyeth
gptkb:Prevnar
gptkb:PCV13
|
|
gptkbp:bfsLayer
|
5
|